NCT05342948View on ClinicalTrials.gov

Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients

CompletedOBSERVATIONAL
Enrollment

583

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Recurrent Pregnancy Loss
Trial Locations (1)

9000

The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

Aalborg University Hospital

OTHER

NCT05342948 - Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients | Biotech Hunter | Biotech Hunter